OCI NV (OCI.AS) Stock Fundamental Analysis
AMS:OCI - Euronext Amsterdam - NL0010558797 - Common Stock - Currency: EUR
OCI gets a fundamental rating of 3 out of 10. The analysis compared the fundamentals against 66 industry peers in the Chemicals industry. OCI has a bad profitability rating. Also its financial health evaluation is rather negative. OCI has a expensive valuation and it also scores bad on growth.
1. Profitability
1.1 Basic Checks
OCI had negative earnings in the past year.
OCI had a positive operating cash flow in the past year.
The reported net income has been mixed in the past 5 years: OCI reported negative net income in multiple years.
In the past 5 years OCI always reported a positive cash flow from operatings.
1.2 Ratios
The Return On Assets of OCI (-5.28%) is worse than 71.21% of its industry peers.
OCI has a Return On Equity of -51.53%. This is amonst the worse of the industry: OCI underperforms 83.33% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -5.28% | ||
| ROE | -51.53% | ||
| ROIC | N/A |
ROA(3y)41.1%
ROA(5y)25.43%
ROE(3y)77.65%
ROE(5y)49.16%
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
OCI's Profit Margin has improved in the last couple of years.
OCI's Gross Margin of 2.23% is on the low side compared to the rest of the industry. OCI is outperformed by 87.88% of its industry peers.
In the last couple of years the Gross Margin of OCI has declined.
OCI does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | 2.23% |
OM growth 3YN/A
OM growth 5YN/A
PM growth 3Y283.84%
PM growth 5YN/A
GM growth 3Y-81.68%
GM growth 5Y-54.61%
2. Health
2.1 Basic Checks
OCI does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, OCI has about the same amount of shares outstanding.
The number of shares outstanding for OCI has been increased compared to 5 years ago.
Compared to 1 year ago, OCI has an improved debt to assets ratio.
2.2 Solvency
Based on the Altman-Z score of 0.20, we must say that OCI is in the distress zone and has some risk of bankruptcy.
OCI's Altman-Z score of 0.20 is on the low side compared to the rest of the industry. OCI is outperformed by 84.85% of its industry peers.
The Debt to FCF ratio of OCI is 44.52, which is on the high side as it means it would take OCI, 44.52 years of fcf income to pay off all of its debts.
Looking at the Debt to FCF ratio, with a value of 44.52, OCI is in line with its industry, outperforming 43.94% of the companies in the same industry.
OCI has a Debt/Equity ratio of 2.03. This is a high value indicating a heavy dependency on external financing.
OCI's Debt to Equity ratio of 2.03 is on the low side compared to the rest of the industry. OCI is outperformed by 89.39% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 2.03 | ||
| Debt/FCF | 44.53 | ||
| Altman-Z | 0.2 |
ROIC/WACCN/A
WACC6.23%
2.3 Liquidity
OCI has a Current Ratio of 1.39. This is a normal value and indicates that OCI is financially healthy and should not expect problems in meeting its short term obligations.
With a Current ratio value of 1.39, OCI is not doing good in the industry: 69.70% of the companies in the same industry are doing better.
OCI has a Quick Ratio of 1.37. This is a normal value and indicates that OCI is financially healthy and should not expect problems in meeting its short term obligations.
Looking at the Quick ratio, with a value of 1.37, OCI is in the better half of the industry, outperforming 71.21% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.39 | ||
| Quick Ratio | 1.37 |
3. Growth
3.1 Past
The earnings per share for OCI have decreased strongly by -123.19% in the last year.
Measured over the past years, OCI shows a very strong growth in Earnings Per Share. The EPS has been growing by 105.88% on average per year.
The Revenue for OCI has decreased by -58.51% in the past year. This is quite bad
The Revenue for OCI have been decreasing by -20.30% on average. This is quite bad
EPS 1Y (TTM)-123.19%
EPS 3Y105.88%
EPS 5YN/A
EPS Q2Q%164.52%
Revenue 1Y (TTM)-58.51%
Revenue growth 3Y-46.36%
Revenue growth 5Y-20.3%
Sales Q2Q%-11.72%
3.2 Future
The Earnings Per Share is expected to grow by 71.49% on average over the next years. This is a very strong growth
OCI is expected to show a decrease in Revenue. In the coming years, the Revenue will decrease by -1.74% yearly.
EPS Next Y770.92%
EPS Next 2Y251.29%
EPS Next 3Y133.31%
EPS Next 5Y71.49%
Revenue Next Year-27.81%
Revenue Next 2Y-14.07%
Revenue Next 3Y-23.72%
Revenue Next 5Y-1.74%
3.3 Evolution
Although the future EPS growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
4. Valuation
4.1 Price/Earnings Ratio
The Price/Earnings Ratio is negative for OCI. In the last year negative earnings were reported.
OCI is valuated rather expensively with a Price/Forward Earnings ratio of 19.67.
The rest of the industry has a similar Price/Forward Earnings ratio as OCI.
The average S&P500 Price/Forward Earnings ratio is at 22.13. OCI is around the same levels.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | 19.67 |
4.2 Price Multiples
OCI's Price/Free Cash Flow is on the same level as the industry average.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 34.22 | ||
| EV/EBITDA | N/A |
4.3 Compensation for Growth
OCI's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
OCI's earnings are expected to grow with 133.31% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y251.29%
EPS Next 3Y133.31%
5. Dividend
5.1 Amount
No dividends for OCI!.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
AMS:OCI (5/29/2025, 7:00:00 PM)
7.71
-0.14 (-1.78%)
Chartmill FA Rating
GICS SectorMaterials
GICS IndustryGroupMaterials
GICS IndustryChemicals
Earnings (Last)
Earnings (Next)
Inst Owners32.2%
Inst Owner ChangeN/A
Ins Owners8.71%
Ins Owner ChangeN/A
Market Cap1.63B
Analysts80
Price Target14.03 (81.97%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Yearly Dividend13.49
Dividend Growth(5Y)N/A
DP-36.26%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)486.8%
Min EPS beat(2)232.01%
Max EPS beat(2)741.58%
EPS beat(4)2
Avg EPS beat(4)85.49%
Min EPS beat(4)-492.57%
Max EPS beat(4)741.58%
EPS beat(8)3
Avg EPS beat(8)31.49%
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)2
Avg Revenue beat(2)37.56%
Min Revenue beat(2)20.15%
Max Revenue beat(2)54.98%
Revenue beat(4)2
Avg Revenue beat(4)8.41%
Min Revenue beat(4)-23.05%
Max Revenue beat(4)54.98%
Revenue beat(8)5
Avg Revenue beat(8)21.58%
Revenue beat(12)9
Avg Revenue beat(12)32.19%
Revenue beat(16)12
Avg Revenue beat(16)36.43%
PT rev (1m)-14%
PT rev (3m)-14%
EPS NQ rev (1m)0%
EPS NQ rev (3m)0%
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0%
Revenue NY rev (1m)-15.32%
Revenue NY rev (3m)-24.72%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | 19.67 | ||
| P/S | 0.41 | ||
| P/FCF | 34.22 | ||
| P/OCF | 3.33 | ||
| P/B | 2 | ||
| P/tB | 2.13 | ||
| EV/EBITDA | N/A |
EPS(TTM)-0.42
EYN/A
EPS(NY)0.39
Fwd EY5.08%
FCF(TTM)0.23
FCFY2.92%
OCF(TTM)2.31
OCFY29.99%
SpS19.03
BVpS3.85
TBVpS3.63
PEG (NY)N/A
PEG (5Y)N/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -5.28% | ||
| ROE | -51.53% | ||
| ROCE | N/A | ||
| ROIC | N/A | ||
| ROICexc | N/A | ||
| ROICexgc | N/A | ||
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | 2.23% | ||
| FCFM | 1.18% |
ROA(3y)41.1%
ROA(5y)25.43%
ROE(3y)77.65%
ROE(5y)49.16%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3Y283.84%
PM growth 5YN/A
GM growth 3Y-81.68%
GM growth 5Y-54.61%
F-Score3
Asset Turnover0.51
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 2.03 | ||
| Debt/FCF | 44.53 | ||
| Debt/EBITDA | N/A | ||
| Cap/Depr | -4159.17% | ||
| Cap/Sales | 10.96% | ||
| Interest Coverage | N/A | ||
| Cash Conversion | N/A | ||
| Profit Quality | N/A | ||
| Current Ratio | 1.39 | ||
| Quick Ratio | 1.37 | ||
| Altman-Z | 0.2 |
F-Score3
WACC6.23%
ROIC/WACCN/A
Cap/Depr(3y)137.7%
Cap/Depr(5y)97.09%
Cap/Sales(3y)24.99%
Cap/Sales(5y)17.3%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-123.19%
EPS 3Y105.88%
EPS 5YN/A
EPS Q2Q%164.52%
EPS Next Y770.92%
EPS Next 2Y251.29%
EPS Next 3Y133.31%
EPS Next 5Y71.49%
Revenue 1Y (TTM)-58.51%
Revenue growth 3Y-46.36%
Revenue growth 5Y-20.3%
Sales Q2Q%-11.72%
Revenue Next Year-27.81%
Revenue Next 2Y-14.07%
Revenue Next 3Y-23.72%
Revenue Next 5Y-1.74%
EBIT growth 1Y-118.58%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year309.47%
EBIT Next 3Y-17.67%
EBIT Next 5Y23.97%
FCF growth 1Y-95.97%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-71.4%
OCF growth 3Y-68.9%
OCF growth 5Y-27.39%